Non-oncogenic addicted NSCLC patients: What is the best approach?

Date 27 September 2014
Event ESMO 2014
Session Systemic treatment of metastatic NSCLC
Topics Cytotoxic agents
Non-small-cell lung cancer
Therapy
Biological therapy
Presenter Benjamin Besse
Authors B. Besse
  • Dept. Of Medicine, Institut de Cancérologie Gustave Roussy, 94805 - Villejuif/FR